Euphylong
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
It has been recognized recently that theophylline possesses anti-inflammatory effects that could be of clinical interest in…
In a multiple-dose crossover study in 18 healthy male volunteers the steady-state pharmacokinetics of Euphylong, which has been…
24 patients with COPD and delta FEV1 greater than 15% were included in a double-blind crossover study. 7 dropouts due to…
This contribution attempts to relate the in-vitro drug release properties of theophylline from Euphylong pellets to serum…
Euphylong is a sustained-release product consisting of encapsulated pellets covered with a porous membrane. Since the mechanism…
Euphylong is a new anhydrous theophylline sustained-release pellet formulation developed for once-daily administration in the…
Although bioequivalence between products has gained considerable importance over the last few years, the concept has not yet been…
The in-vitro release method used within the scope of the galenical development of Euphylong pellets and subsequently employed on…
Three separate single-dose, randomized, cross-over studies in normal, healthy volunteers were performed to investigate the…
In a randomized, multiple-dose, cross-over study, serum theophylline concentrations (STC) were compared in 12 healthy volunteers…